Physical Therapists in Middleton, WI Accepting Medicare

50 Physical Therapists found. Showing 41 - 50

Nissenbaum And Schleusner Pro Physical Therapy Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3031 Pleasant View Rd, Middleton, WI 53562 Phone: 608-841-1290    Fax: 608-841-1299

Stephanie Hartung, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 6630 University Ave, Middleton, WI 53562 Phone: 608-263-8412

Karen Ann Kohls, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9401 Old Sauk Rd, Middleton, WI 53562 Phone: 608-203-8102

David D Bogenrief, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2030 Pinehurst Dr, Middleton, WI 53562 Phone: 608-203-2273

Ann Carol Bruhn, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6630 University Ave, Uwhealth Middleton Rehab, Middleton, WI 53562 Phone: 608-263-8412

Codi William Halbur, PT, DPT Physical Therapist - Neurology Medicare: Not Enrolled in Medicare Practice Location: 6630 University Ave, Middleton, WI 53562 Phone: 608-263-8412

Claire M Peterson, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 8391 Greenway Blvd Ste 130, Middleton, WI 53562 Phone: 608-790-9635

Winston Grady Voncarlowitz, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2237 Deming Way, Middleton, WI 53562 Phone: 608-417-8500

Gina Craig Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2521 Allen Boulevard, Middleton, WI 53562 Phone: 608-417-3370

Maria Teresa Schumacher, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8301 Old Sauk Rd, Middleton, WI 53562 Phone: 608-662-8868    Fax: 608-662-8800

News Archive

Marburg outbreak - experts struggling to get message across

Disease experts in Angola say it will be weeks before it is determined whether the on-going Marburg crisis can be averted in Angola where the disease has already killed at least 194 people.

Update on the status of Somaxon Pharmaceuticals' NDA for Silenor provided

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.

Study: Epilepsy patients want physicians to share information about rare risk of death

People with epilepsy want their health care providers to tell them about a rare risk of death associated with the disorder, according to a preliminary study released today that will be presented at the American Academy of Neurology's 69th Annual Meeting in Boston, April 22 to 28, 2017.

Parkinson's patients with higher urate levels in their blood and CSF had slower functional decline

Individuals with Parkinson's disease who have higher levels of a metabolite called urate in their blood and in cerebrospinal fluid (CSF) have a slower rate of disease progression, according to a study funded by the National Institutes of Health.

Simple tests can help differentiate between early-stage PD and atypical parkinsonism

Two simple tests conducted during the neurological exam can help clinicians differentiate between early-stage Parkinson's disease (PD) and atypical parkinsonism. By asking patients to perform a tandem gait test and inquiring whether they are still able to ride a bicycle, clinicians can ascertain whether medio-lateral balance is impaired, a defining characteristic of atypical parkinsonism.

Read more Medical News

› Verified 3 days ago

• 1
• 2
• 3(current)